-
Posted: January 26th, 2023, 3:00pm GMT
Conditions: Astroblastoma; BCOR ITD Sarcoma; CNS Sarcoma; Unclassified Tumor, Malignant
Intervention:
Sponsor: Children's National Research Institute
Recruiting
-
Posted: January 26th, 2023, 3:00pm GMT
Condition: Brain Metastases
Interventions: Drug: Niraparib; Drug: Dostarlimab
Sponsor: M.D. Anderson Cancer Center
Not yet recruiting
-
Posted: January 20th, 2023, 3:00pm GMT
Conditions: Brain Metastases; Nonsmall Cell Lung Cancer Stage III
Interventions: Diagnostic Test: MRI of the Brain; Other: Blood draws; Other: Quality of Life Questionnaires
Sponsors: Wake Forest University Health Sciences; National Cancer Institute (NCI)
Not yet recruiting
-
Posted: January 19th, 2023, 3:00pm GMT
Conditions: Brain Metastases, Adult; Non Small Cell Lung Cancer; Breast Cancer
Interventions: Dietary Supplement: Silibinin; Other: Placebo
Sponsor: Alessia Pellerino
Recruiting
-
Posted: January 18th, 2023, 3:00pm GMT
Conditions: Tumor, Brain; Tumor, Breast; Tumor Skin
Intervention:
Sponsor: National Taiwan University Hospital
Not yet recruiting
-
Posted: January 16th, 2023, 3:00pm GMT
Conditions: Malignant Glioma of Brain; Astrocytoma; Malignant Astrocytoma; Brain Tumor; Glioma; Brain Cancer; Glioblastoma; Glioblastoma Multiforme; GBM
Intervention: Biological: Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
Sponsor: Henry Ford Health System
Recruiting
-
Posted: January 12th, 2023, 3:00pm GMT
Conditions: Primary Central Nervous System Lymphoma; Secondary Central Nervous System Lymphoma; Relapsed Cancer; Refractory Cancer
Interventions: Drug: Pemetrexed; Drug: Zanubrutinib; Procedure: Autologous Stem Cell Transplant (ASCT); Radiation: Whole Brain Radiation Therapy (WBRT)
Sponsors: Baptist Health South Florida; BeiGene
Not yet recruiting
-
Posted: January 10th, 2023, 3:00pm GMT
Condition: Spinal Cord Tumor
Intervention: Procedure: surgical excision
Sponsor: Sohag University
Recruiting
-
Posted: January 10th, 2023, 3:00pm GMT
Condition: Intracranial Tumors
Intervention: Device: early detection test
Sponsors: Zhujiang Hospital; Guangzhou Burning Rock Dx Co., Ltd.
Recruiting
-
Posted: January 9th, 2023, 3:00pm GMT
Conditions: Healthy Volunteers; Recurrent Glioma; Brain Metastases From Extra-cranial Solid Tumors
Intervention: Drug: [F-18]MeFAMP PET
Sponsor: University of Alabama at Birmingham
Not yet recruiting
-
Posted: January 6th, 2023, 3:00pm GMT
Conditions: Metastatic Solid Tumor; Brain Metastases
Interventions: Drug: Trastuzumab emtansine; Drug: Tucatinib
Sponsors: M.D. Anderson Cancer Center; Genentech, Inc.; Seagen Inc.
Not yet recruiting
-
Posted: January 5th, 2023, 3:00pm GMT
Conditions: Medulloblastoma; Central Nervous System Tumor, Pediatric; Ependymoma; Germ Cell Tumor; Glioma; Brain Tumor, Pediatric
Intervention:
Sponsor: Beijing Tiantan Hospital
Recruiting
-
Posted: December 30th, 2022, 3:00pm GMT
Condition: Malignant Brain Tumor
Intervention: Other: NODDI TRACT
Sponsor: GCS Ramsay Santé pour l'Enseignement et la Recherche
Not yet recruiting
-
Posted: December 30th, 2022, 3:00pm GMT
Condition: Melanoma Metastatic in the Brain
Interventions: Drug: CA-4948; Drug: Pembrolizumab
Sponsors: University of Florida; Merck Sharp & Dohme LLC
Not yet recruiting
-
Posted: December 23rd, 2022, 3:00pm GMT
Condition: Spinal Cord Tumor of Cervical Spine
Intervention: Diagnostic Test: MRI scan
Sponsor: University of Oxford
Recruiting
-
Posted: December 23rd, 2022, 3:00pm GMT
Condition: Glioblastoma
Interventions: Biological: Autologous genetically modified gamma-delta T cells; Biological: Allogeneic genetically modified gamma-delta T cells
Sponsor: In8bio Inc.
Not yet recruiting
-
Posted: December 21st, 2022, 3:00pm GMT
Condition: Primary Brain Tumor
Intervention:
Sponsor: University Hospital, Strasbourg, France
Recruiting
-
Posted: December 21st, 2022, 3:00pm GMT
Conditions: Brain Tumor; Head and Neck Cancer
Interventions: Radiation: substructure informed planning; Other: Neurocognitive Testing; Diagnostic Test: MRI
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Not yet recruiting
-
Posted: December 21st, 2022, 3:00pm GMT
Condition: Pituitary Tumor
Intervention: Other: Nasal saline irrigation
Sponsors: Nicole Hill; Barrow Brain and Spine
Recruiting
-
Posted: December 7th, 2022, 3:00pm GMT
Condition: Metastatic Melanoma
Intervention: Biological: Lifileucel (LN-144)
Sponsors: Memorial Sloan Kettering Cancer Center; Iovance Biotherapeutics, Inc.
Recruiting
-
Posted: November 17th, 2022, 3:00pm GMT
Condition: Brain Metastases, Adult
Intervention: Drug: Patritumab deruxtecan
Sponsors: Mustafa Khasraw, MBChB, MD, FRCP, FRACP; Daiichi Sankyo, Inc.
Not yet recruiting
-
Posted: September 2nd, 2022, 2:00pm GMT
Condition: Biochemically Recurrent Prostate Cancer
Interventions: Drug: Darolutamide(BAY1841788, Nubeqa); Drug: Enzalutamide
Sponsor: Bayer
Recruiting
-
Posted: August 17th, 2022, 2:00pm GMT
Conditions: Childhood Cancer; Childhood Solid Tumor; Childhood Brain Tumor; Childhood Leukemia; Refractory Cancer; Relapsed Cancer
Interventions: Genetic: Whole Genome Sequencing; Genetic: RNA seq; Genetic: DNA Methylation; Genetic: Targeted Panel Sequencing; Genetic: High Throughput Sequencing (in vitro); Genetic: Patient Derived Xenograft (PDX)(in vivo); Other: Liquid Biopsy
Sponsors: Australian & New Zealand Children's Haematology/Oncology Group; Children's Cancer Institute; Minderoo Foundation; Medical Research Future Fund
Recruiting
-
Posted: August 15th, 2022, 2:00pm GMT
Conditions: Cancer; Solid Tumor; Solid Carcinoma; Advanced Cancer; DIPG Brain Tumor; Ovary Cancer; Breast Cancer; Papillary Thyroid Cancer; Head and Neck Cancer; Gastric Cancer; Nsclc; Mesotheliomas Pleural; Mesothelioma Peritoneum; Esophageal Cancer; Diffuse Midline Glioma, H3 K27M-Mutant; Endometrial Cancer; Cervical Cancer; Melanoma; Colorectal Cancer
Interventions: Drug: AMXT1501; Drug: DFMO
Sponsor: Aminex Therapeutics, Inc.
Recruiting
-
Posted: July 29th, 2022, 2:00pm GMT
Conditions: ALL, Adult; CNS Tumor; Solid Tumor
Interventions: Other: Neurocognitive (Thinking) Testing; Diagnostic Test: CNS Vital Signs (Thinking) Testing; Other: Health Questionnaires, Sleep Surveys & Sleep Diary; Diagnostic Test: Echocardiography/EKG; Diagnostic Test: Pulmonary Function; Device: Remote Polysomnography; Diagnostic Test: Physical Function
Sponsor: St. Jude Children's Research Hospital
Not yet recruiting
-
Posted: July 1st, 2022, 2:00pm GMT
Conditions: Tumor, Cerebral Ventricle; Tumor, Cerebellar; Aneurysm Cerebral; Trauma, Brain
Intervention: Device: Lyoplant®
Sponsor: Aesculap AG
Not yet recruiting
-
Posted: June 21st, 2022, 2:00pm GMT
Conditions: Hemangioblastoma of CNS; Von Hippel-Lindau Disease
Interventions: Drug: Propranolol; Other: follow-up
Sponsors: Assistance Publique - Hôpitaux de Paris; Agence Générale des Equipements et Produits de Santé
Recruiting
-
Posted: June 7th, 2022, 2:00pm GMT
Conditions: Atypical Teratoid Rhabdoid Tumor; INI1 (SMARCB1)-Deficient Primary CNS Malignant Tumors; SMARCA4-deficient Primary CNS Malignant Tumors; Malignant Rhabdoid Tumor (MRT); Rhabdoid Tumor of the Kidney (RTK); Epithelioid Sarcoma; Chordoma
Interventions: Drug: Tazemetostat; Drug: Nivolumab; Drug: Ipilimumab
Sponsors: Susan Chi, MD; Bristol-Myers Squibb; Epizyme, Inc.
Recruiting
-
Posted: May 23rd, 2022, 2:00pm GMT
Conditions: Breast Neoplasms; Brain Neoplasms; Neoplasms by Site; Neoplasms; Breast Diseases; Central Nervous System Neoplasms; Brain Diseases; Central Nervous System Diseases
Interventions: Drug: Elacestrant; Drug: Abemaciclib
Sponsor: Stemline Therapeutics, Inc.
Recruiting
-
Posted: February 3rd, 2022, 3:00pm GMT
Condition: CNS Lymphoma
Intervention: Drug: 68Ga-PTF
Sponsor: PentixaPharm GmbH
Recruiting
-
Posted: October 21st, 2021, 2:00pm GMT
Conditions: GBM; Glioma Glioblastoma Multiforme; Tumor, Brain
Intervention: Diagnostic Test: Whole Brain Spectroscopy Imaging Array Mapping Layout
Sponsors: Abramson Cancer Center of the University of Pennsylvania; NovoCure Ltd.; National Institutes of Health (NIH); National Cancer Institute (NCI)
Recruiting
-
Posted: August 6th, 2021, 2:00pm GMT
Conditions: Atypical Choroid Plexus Papilloma; Choroid Plexus Carcinoma
Interventions: Drug: Melphalan; Drug: Carboplatin; Drug: Topotecan
Sponsor: Weill Medical College of Cornell University
Recruiting
-
Posted: August 3rd, 2021, 2:00pm GMT
Conditions: Central Nervous System Neoplasm; Leptomeningeal Neoplasm; Metastatic Malignant Neoplasm in the Brain; Primary Brain Neoplasm
Interventions: Other: Electronic Health Record Review; Other: Survey Administration
Sponsor: M.D. Anderson Cancer Center
Recruiting
-
Posted: July 26th, 2021, 2:00pm GMT
Condition: Glioblastoma Multiforme
Interventions: Drug: Pembrolizumab; Radiation: Stereotactic Radiation Therapy; Procedure: Surgical Resection
Sponsors: Chirag G. Patil; Merck Sharp & Dohme LLC; National Cancer Institute (NCI)
Recruiting
-
Posted: May 18th, 2021, 2:00pm GMT
Conditions: Neurocognitive Deficit; Quality of Life; Activities of Daily Living
Interventions: Radiation: Stereotactic RadioTherapy; Radiation: Whole Brain Irradiation
Sponsors: Mediterranean Institute of Oncology; University of Messina; University of Palermo
Recruiting
-
Posted: March 23rd, 2021, 2:00pm GMT
Condition: Brain Neoplasm
Intervention: Procedure: Brain Surgery
Sponsors: Mayo Clinic; National Cancer Institute (NCI)
Recruiting
-
Posted: February 21st, 2021, 3:00pm GMT
Condition: Non-small Cell Lung Cancer
Interventions: Drug: Osimertinib (AZD9291) pemetrexed cisplatin or carboplatin; Drug: Placebo for osimertinib (AZD9291) pemetrexed cisplatin or carboplatin
Sponsors: AstraZeneca; Parexel
Recruiting
-
Posted: February 4th, 2021, 3:00pm GMT
Conditions: Central Nervous System Infections; Central Nervous System Complication; Infectious Disease of Nervous System; Blood Disease; Blood Cancer; Infection
Intervention:
Sponsor: European Society for Blood and Marrow Transplantation
Recruiting
-
Posted: August 12th, 2020, 2:00pm GMT
Conditions: Acral Lentiginous Melanoma; Clinical Stage IV Cutaneous Melanoma AJCC v8; Metastatic Cutaneous Melanoma; Metastatic Malignant Neoplasm in the Brain; Metastatic Melanoma; Metastatic Mucosal Melanoma; Pathologic Stage IV Cutaneous Melanoma AJCC v8
Interventions: Drug: Binimetinib; Drug: Encorafenib; Biological: Ipilimumab; Biological: Nivolumab
Sponsors: Southwest Oncology Group; National Cancer Institute (NCI)
Recruiting
-
Posted: July 17th, 2020, 2:00pm GMT
Condition: Brain Metastases
Interventions: Procedure: Brain Surgery; Radiation: Stereotactic Radiosurgery
Sponsor: AHS Cancer Control Alberta
Recruiting
-
Posted: April 24th, 2020, 2:00pm GMT
Condition: Cancer
Intervention: Device: MR scan with the Alberta linac-MR P3 system
Sponsor: AHS Cancer Control Alberta
Recruiting
-
Posted: April 16th, 2020, 2:00pm GMT
Conditions: Anatomic Stage IV Breast Cancer AJCC v8; Metastatic Malignant Neoplasm in the Brain; Metastatic Triple-Negative Breast Carcinoma; Prognostic Stage IV Breast Cancer AJCC v8
Interventions: Biological: Anti-HER2/HER3 Dendritic Cell Vaccine; Biological: Pembrolizumab
Sponsors: Roswell Park Cancer Institute; United States Department of Defense
Recruiting
-
Posted: February 13th, 2020, 3:00pm GMT
Condition: Brain Cancer
Interventions: Behavioral: eSNAP; Behavioral: Caregiver Navigator
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Recruiting
-
Posted: September 30th, 2019, 2:00pm GMT
Condition: CNS Metastases
Interventions: Other: Samples collection: Plasma; Other: Samples collection: CSF; Other: Samples collection: Non-CNS Metastatic Tumour Tissue; Other: Brain MRI; Other: Samples collection: Serum
Sponsors: Jules Bordet Institute; La Fondation contre le cancer, Belgique; Les Amis de l'Institut Bordet; Bristol-Myers Squibb; Fondation Cancer, Luxembourg
Recruiting
-
Posted: September 23rd, 2019, 2:00pm GMT
Conditions: Diffuse Intrinsic Pontine Glioma; High Grade Glioma; Embryonal Tumor; Ependymal Tumor
Interventions: Genetic: (C7R)-GD2.CART cells; Drug: Cyclophosphamide; Drug: Fludarabine
Sponsors: Baylor College of Medicine; Center for Cell and Gene Therapy, Baylor College of Medicine; The Faris Foundation
Recruiting
-
Posted: November 15th, 2018, 3:00pm GMT
Conditions: Malignant Neoplasm; Metastatic Malignant Neoplasm in the Brain
Interventions: Other: Quality-of-Life Assessment; Other: Questionnaire Administration; Radiation: Stereotactic Radiosurgery
Sponsors: M.D. Anderson Cancer Center; National Cancer Institute (NCI)
Recruiting
-
Posted: September 19th, 2018, 2:00pm GMT
Condition: Pituitary Neoplasm
Intervention: Other: ESC
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Recruiting
-
Posted: August 23rd, 2018, 2:00pm GMT
Condition: Breast Cancer
Intervention: Radiation: 1-3 Fraction Stereotactic Body Radiation Therapy
Sponsor: University of Alabama at Birmingham
Recruiting
-
Posted: February 6th, 2018, 3:00pm GMT
Conditions: Recurrent Glioblastoma Multiforme; Primary Glioblastoma Multiforme; Brain Neoplasms, Malignant; Leptomeningeal Disease (LMD)
Interventions: Radiation: Radiation Therapy; Drug: AZD1390
Sponsor: AstraZeneca
Recruiting
-
Posted: November 1st, 2017, 2:00pm GMT
Condition: Breast Cancer Metastatic
Intervention: Drug: Irinotecan Hydrochloride
Sponsor: MedSIR
Recruiting
-
Posted: December 31st, 2015, 3:00pm GMT
Conditions: Diffuse Intrinsic Pontine Glioma; Brain Tumor, Recurrent; Solid Tumor, Recurrent; Neuroblastoma, Recurrent, Refractory; Ewing Sarcoma, Recurrent, Refractory; Rhabdomyosarcoma, Recurrent, Refractory; Osteosarcoma, Recurrent, Refractory; Rhabdoid Tumor, Recurrent, Refractory
Intervention: Drug: Abemaciclib
Sponsor: Emory University
Recruiting
-
Posted: November 13th, 2014, 3:00pm GMT
Conditions: Pituitary Neoplasms; Adenoma
Intervention: Drug: cabergoline
Sponsors: St. Olavs Hospital; Norwegian University of Science and Technology
Recruiting